This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2024!
9-12 April 2024Messe Wien Congress Centre, Vienna
Register by 26 Jan Save £700
Menu
Book
Key Sessions
Steffen Lang
Keynote Address
Novartis
Nigel Titchener-Hooker, Ph.D.
Keynote Address: 40 years of Drug Development
University College London
keyboard_arrow_right

Day Two - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search

Day Two - CET/CEST (Cent Europe Summer, GMT+2)

search
07:30 - 08:30
Welcome Coffee and Registration
Showing 1 of 1 Streams
08:30 - 09:00
Plenary Keynote Presentation by Sartorius
09:00 - 09:35
Keynote Address
  • Steffen Lang - President, Operations, Novartis
09:35 - 10:05
Plenary Keynote Presentation by Cytiva
10:05 - 10:55
Morning Refreshment Break in Exhibition & Poster Hall
Showing 5 of 5 Streams
10:55 - 11:00
Chairperson's Opening Remarks
11:00 - 11:30
Using Stable producer cell lines for manufacturing of lentiviral vectors
  • Nikki Lal - Scientist, CSL Behring Innovation GmbH
11:30 - 12:00
CLD Toolkit To Help Identify Expression Limitation and Bottlenecks
  • Julie Frentzel - Scientist, Merck
12:00 - 12:30
Scientific Showcase by Advanced Instruments
10:55 - 11:00
Chairperson's Opening Remarks
11:00 - 11:30
Incorporating new feed components in process development: a strategic approach based on the impact of dipeptides on clone selection
  • Gesthimani Barmpouteli - Scientist, UCB
11:30 - 12:00
Scaling-up therapeutic bioproduction with CELLiST BASAL CHO MX medium
  • Leslie Wolfe, PhD - Director, Downstream Process Development, KBI Biopharma
12:00 - 12:30
Scientific Track Presentation
10:55 - 11:00
Chairperson's Opening Remarks
11:00 - 11:30
Keynote Address: 40 years of Drug Development
  • Nigel Titchener-Hooker, Ph.D. - Professor, University College London
11:30 - 12:00
Optimized and Robust Raman Calibration Method
  • Patrick Romann - ., Merck Serono
12:00 - 12:30
Scientific Track Presentation
10:55 - 11:00
Chair’s Welcome Remarks
  • Weitao Jia - Director, CMC Analytical Development Technical Operations, Ultragenyx
11:00 - 11:30
Strategic outsourcing of biologics CMC development and manufacturing
  • Ulrich Ruemenapp - Head of Launch Preparation, Bayer AG
11:30 - 12:00
Closed systems and A risk-based approach to filter integrity testing requirements for biologics drug substance manufacturers
  • Richard McCarthy - Representative, BioPhorum
12:00 - 12:30
Scientific Track Presentation (Sponsor)
10:55 - 11:00
Chair’s Welcome Remarks
  • Angela Vollstedt - Director, Cell & Gene Therapies Portfolio Management, Novartis
11:00 - 11:30
Gene Therapy Development: from process design to process intensification at warp speed
  • Nic Preyat - Associate Director, Gene Therapy CMC Development, UCB Pharma
11:30 - 12:00
rAVV Capsid Stability During Chromatographic Purification
  • Vijesh Kumar - Lead Scientist, Spark Therapeutics
12:00 - 12:30
Scientific Track Presentation (Sponsor)
12:30 - 12:55
Lunch in Exhibtion & Poster Hall ( 1 hr 30 mins)
12:55 - 13:40
Live Labs
13:40 - 14:00
Lunch in Exhibition & Poster Hall
Showing 5 of 5 Streams
14:00 - 14:30
Microbial based systems for production of diverse vaccines platforms, from complex nanoparticles and VLPs, to enabling proteins for RNA based therapies
  • Jonathan Jones - Upstream Scientist, CPI
14:30 - 15:00
Cell Lines for Cultured Meat
  • Gaye Cetinkaya Campari - Team Lead Cell Line Development, BLUU GmbH
15:00 - 15:30
Scientific Track Presentation
14:00 - 14:30
Taking Care of Your Cell Culture: Cell Culture Maintenance
  • Jennifer Smith - Senior R&D Manager, Cell Culture & Fermentation Sciences, AstraZeneca
14:30 - 15:00
Tech transfer considerations for introduction of perfusion technology at large scale manufacturing
  • Sinead Dullaghan - Dullaghan Sr. Principal Scientist TSMS, Eli Lilly
15:00 - 15:30
Scientific Track Presentation
14:00 - 14:30
CSLs concept of the Lab of the Future – Accelerating Product Development through Automation and Smart PD
  • Lars Robbel - Senior Manager - Early Stage Process Development, CSL Behring Innovation GmbH
14:30 - 15:00
The Need for Seamless Data Management, Data Contextualization and Data Analysis to Ensure Data Integrity & Data Maturity
  • Christoph Herwig - Founder, Lisalis GmbH
15:00 - 15:30
Scientific Track Presentation
14:00 - 14:30
Strategic technology transfer and outsourcing to accelerate pipeline development and commercialisation
  • Weitao Jia - Director, CMC Analytical Development Technical Operations, Ultragenyx
14:30 - 15:00
Strategies for distributed mRNA and saRNA manufacturing
  • Harris Makatsoris - Academics Professor of Sustainable Manufacturing Systems, King's College London
15:00 - 15:30
Scientific Track Presentation (Sponsor)
14:00 - 14:30
Development of iPSC derived NK cell therapy for immune oncology
  • Tanya Ponomaryov - Principal Scientist, Plasticell Ltd
14:30 - 15:00
Streamlined process for AAV purification and analytics
  • Wei Zhang - Principal Scientist & DSP Group Head (Biotherapeutics Purification and Analytics), A*STAR Bioprocessing Technology Institute, Singapore
15:00 - 15:30
Scientific Track Presentation (Sponsor)
15:30 - 16:15
Afternoon Break in Exhibition Hall
Showing 5 of 5 Streams
16:15 - 17:15
Panel Discussion: Optimizing Expression of Novel Biologics
  • Nikki Lal - Scientist, CSL Behring Innovation GmbH
  • Jonathan Jones - Upstream Scientist, CPI
16:15 - 16:45
Bispecific / Multi Specifics Case Study: Optimising Expression, Product Quality and Yield in Upstream Process Development
  • Nikita Patel - Senior Scientist, Inmune Bio
16:45 - 17:15
Overcoming CMC Challenges in the Development of an Oncolytic Virus
  • Ingo Gorr - Director, Head of Early Stage Bioprocess Development (USP & DSP), Boehringer Ingelheim
16:15 - 16:45
Product Sieving Understanding in Different TFF Operation Modes in Dynamic Perfusion Cultures
  • Dominik Schieman - ., Novartis Pharma AG
16:45 - 17:15
Enabling lowest COGS Through the Latest GMP-Scale Continuous Manufacturing Technology
16:15 - 16:45
Redefining the process control program for biotherapeutic regulatory filings
  • Christina Calabrese - Sr. Process Scientist, Process Control, Regeneron
16:45 - 17:15
Online Presentation: Pharma 4.0, FDA/FRAME and Digital Twins: Enabling Advanced Manufacturing and Digital Transformation in Pharma through Cross-Collaborative Partnerships
  • Douglas Kiehl - Senior Director, Bioproduct Research & Development, Eli Lilly and Company
16:15 - 16:45
Evolution of the regulatory landscape and technological innovation for ATMPs: Harmonising innovation and regulation to foster greater success
  • Angela Vollstedt - Director, Cell & Gene Therapies Portfolio Management, Novartis
16:45 - 17:15
Downstream processing and in process control of viral vectors
  • Alois Jungbauer - Professor, Dept. of Biotechnology, University of Natural Resources and Applied Life Sciences
17:15 - 19:30
Offsite Reception
Day One
NextDay Three
Filter
Streams
Choose Day